Through the power of strategic, well-built partnerships, CVS Health helps employees earn degrees — and at no cost to them.

The company boosts its full-year guidance range for adjusted earnings on the heels of a strong second quarter.

CVS Health topped Wall Street expectations for the second quarter and it's hiking its full-year forecast again, as the health ...

Shares of CVS Health jumped on Thursday after the healthcare giant posted better-than-expected second-quarter results and ...

CVS Health raised its full-year profit forecast after exceeding Wall Street quarterly earnings estimates on Thursday, as ...

Investors with an interest in Medical Services stocks have likely encountered both CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors? We'll need ...

In the wake of two suicides of Lancaster County pharmacists, a former pharmacy professor has raised the alarm by calling for ...

CVS Joins Race to Sell Cheaper, 'Biosimilar' Drugs Early next year, the chain will start producing a cheaper version of Humira, with other meds to follow. Here's what to know about biosimilar drugs.

CVS Health's troubles haven't been solely on the fundamental side. Indeed, shares have underperformed on the price charts, too, down 18% on a total return basis (price change plus dividends) so ...

CVS Health CVS 0.0% (NYSE: CVS) reported its Q3 results earlier this month, with revenues and earnings beating the street estimates, and we believe that CVS stock is undervalued, as discussed below.

CVS Health on Monday agreed to an $8 billion acquisition of Signify Health, a health care platform that uses analytics and technology to pair clinicians with patients for home-based visits.